RT @henrique_puls: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 https://t.co/3IQp9QKojk
RT @iamritu: #anticoagulation for #COVID19 #microvascular #thrombosis https://t.co/Shaz3W35AJ by @isth use if ⬆️D Dimer, ⬇️plts, ⬇️ fibrin…
#anticoagulation for #COVID19 #microvascular #thrombosis https://t.co/Shaz3W35AJ by @isth use if ⬆️D Dimer, ⬇️plts, ⬇️ fibrinogen (frm ⬆️ plasminogen activator secretion by macrophages, results in plasminogen➡️ plasmin & results in⬇️ESR) & PT prol
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 https://t.co/3IQp9QKojk
@aburnett_PharmD ISTH recs as well: https://t.co/gC3pUFTa8H
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…
RT @santamariaparo: ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 https://t.co/Kfw1dTxH7h
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 https://t.co/Kfw1dTxH7h
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 - Thachil - - Journal of Thrombosis and Haemostasis - Wiley Online Library @AamirNHussain; article I was referring to. We need RCT. BI deaconess is doing one. https://t.co/M
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…
coagulopathy in covid-19. https://t.co/wvS39esxQx
@luisamnMD Regardless of the need for vasopressors or the type of vasopressor being used, this virus seems to wreak havoc on the coagulation cascade (https://t.co/RA03bowUG9). I am not aware of any increased VTE risk with Ang II so far. Regardless, obvious
RT @KashPrime: @Origandclever @maureentaylor31 Not that I've seen, and thrombolytics might be drastic. These folks have come up with a prot…
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…
@KK_NicoDaVinci für Fortgeschrittene: https://t.co/XEygrMlG6M
@Origandclever @maureentaylor31 Not that I've seen, and thrombolytics might be drastic. These folks have come up with a protocol: https://t.co/xEKniuQoJj
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…
RT @KashPrime: Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is thei…
Here's another paper that provides an algorithm for spotting and treating coagulopathies in Covid patients, and here is their algorithm https://t.co/mVLxqWlIkv https://t.co/EVP1jKJJwm
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
@dfaraoni @isth @JerroldLevy @bhwords @drfoxrob @PatriciaLiaw @SarahkMedeiros I am probably the last person qualified to comment but... hard to go against ISTH guidance on managing COVID-19 coagulopathy with heparin/lmwh, esp in critically ill/sic patients
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @aakonc: @Aiims1742 This is indeed accurate and being increasing recognized. @isth just out out guidance on this (bottom line: hospitali…
RT @aakonc: @Aiims1742 This is indeed accurate and being increasing recognized. @isth just out out guidance on this (bottom line: hospitali…
RT @ProfMakris: I do not understand why the new ISTH guideline on COVID-19 coagulopathy recommends replacing fibrinogen to get to a level o…
RT @aakonc: @Aiims1742 This is indeed accurate and being increasing recognized. @isth just out out guidance on this (bottom line: hospitali…
RT @aakonc: @Aiims1742 This is indeed accurate and being increasing recognized. @isth just out out guidance on this (bottom line: hospitali…
RT @aakonc: @Aiims1742 This is indeed accurate and being increasing recognized. @isth just out out guidance on this (bottom line: hospitali…
@Aiims1742 This is indeed accurate and being increasing recognized. @isth just out out guidance on this (bottom line: hospitalized Covid pts should get thromboprophylaxis) https://t.co/974DWkkUIO
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
@sabuqayyas @MikecoolTran @rbhandari_10 ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 https://t.co/2Qz2EmScPs
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @connors_md: only document I can find suggesting that therapeutic anticoagulation is recommended by Chinese in a document in Chinese. Is…
RT @bhwords: Like @ProfMakris I am worried by this guidance because 1) #COVID19 care is based on CLINICAL probs not unvalidated biomarke…
RT @ProfMakris: I do not understand why the new ISTH guideline on COVID-19 coagulopathy recommends replacing fibrinogen to get to a level o…
RT @Stago_Official: Here is the new @isth guidance regarding the management of #coagulopathies in #COVID19 patients: https://t.co/0Evcn779c…
RT @connors_md: only document I can find suggesting that therapeutic anticoagulation is recommended by Chinese in a document in Chinese. Is…
only document I can find suggesting that therapeutic anticoagulation is recommended by Chinese in a document in Chinese. Is full dose anticoag being recommended? Or prophylactic dose 40 mg enoxaprin twice a day or 5000 units unfractionated heparin TID as p
RT @isth: Read the full pdf here: https://t.co/Jgc58PWAFa
@YmaGrebnesi @beachtraumadoc
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NiharikaDixit16: @MazieTsangMD @jungleland @Bloodman @Clotmaster @Svematologist ISTH has come out with interim guidelines https://t.co/…
@MazieTsangMD @jungleland @Bloodman @Clotmaster @Svematologist ISTH has come out with interim guidelines https://t.co/9nKBCDlefW They recommend anticoagulation with heparin based on a study that found a benefit of heparin in patients with Sepsis-induced co
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
RT @NicoleKuderer: @MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeut…
@MKnoll_MD @ISTH Guidance on hypercoaguability & Thromboprophylaxis during #COVID19. In China they recom. even therapeutic anticoag for prophylaxis. @AnnaFalanga19 @ICTHIC https://t.co/DasVOgJu4z cc: @connors_md
RT @ProfMakris: I do not understand why the new ISTH guideline on COVID-19 coagulopathy recommends replacing fibrinogen to get to a level o…
RT @AgustnR67702597: Very important: "prophylactic LMWH should be considered in ALL patients (including non-critically ill) who require hos…
RT @JTHjournal: @isth guidelines by @AnnaFalanga19 @MarcelLevi @marcocattaneo 💉🔬Pls RT #covid19australia #COVID2019 @connors_md @Middeldor…
RT @JTHjournal: @isth guidelines by @AnnaFalanga19 @MarcelLevi @marcocattaneo 💉🔬Pls RT #covid19australia #COVID2019 @connors_md @Middeldor…
RT @Whale_Mockery: @medicalaxioms @Bob_Wachter The Int’l Society for Thrombosis and Hemostasis releases a document recommending monitoring…
RT @AgustnR67702597: Very important: "prophylactic LMWH should be considered in ALL patients (including non-critically ill) who require hos…
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @GendronNico: Totally agree✅. In our center: ▪️ D-dimer and routine hemostasis monitoring for all COVID-19 hospitalized patients. ▪️Pro…
RT @GendronNico: Totally agree✅. In our center: ▪️ D-dimer and routine hemostasis monitoring for all COVID-19 hospitalized patients. ▪️Pro…
RT @milfede: Do NOT treat numbers! High thrombin and fibrinogen are not good fellows! Treating numbers? Better treat physicians’ anxiety. @…
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 https://t.co/KuOBQlSuqX
RT @Whale_Mockery: @medicalaxioms @Bob_Wachter The Int’l Society for Thrombosis and Hemostasis releases a document recommending monitoring…
@gerafomonsalve que no vean esto por ahí... le clavan fibrinógeno al que se mueva...
RT @bhwords: Like @ProfMakris I am worried by this guidance because 1) #COVID19 care is based on CLINICAL probs not unvalidated biomarke…
RT @isth: NEW: Read the @ISTH interim guidance on recognition and management of coagulopathy in #COVID19, published in @JTHjournal https://…
@medicalaxioms @Bob_Wachter The Int’l Society for Thrombosis and Hemostasis releases a document recommending monitoring dimer, PT, plt, fgen, give LMWH at ppx doses to all Covid-19 inpts, no adjustment for weight or dimer. https://t.co/h524ZQSJf9 https:/
RT @milfede: Do NOT treat numbers! High thrombin and fibrinogen are not good fellows! Treating numbers? Better treat physicians’ anxiety. @…
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @bhwords: Like @ProfMakris I am worried by this guidance because 1) #COVID19 care is based on CLINICAL probs not unvalidated biomarke…
#Article apparu dans Journal of Thrombosisn and Haemostasis portant sur les coagulopathies associées au #COVID19 https://t.co/J1uuDp4189
RT @AgustnR67702597: Very important: "prophylactic LMWH should be considered in ALL patients (including non-critically ill) who require hos…
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @ProfMakris: I do not understand why the new ISTH guideline on COVID-19 coagulopathy recommends replacing fibrinogen to get to a level o…
RT @JuanVLlau: Absolutely agree!. No fibrinogen replacement in absence of bleeding. We know that even with 0.70 g/L we can coagulate in abs…
RT @bhwords: Like @ProfMakris I am worried by this guidance because 1) #COVID19 care is based on CLINICAL probs not unvalidated biomarke…
RT @ProfMakris: The most important message in these two papers that are in press in JTH is that all patients with COVID-19 admitted to hosp…
RT @JuanVLlau: Absolutely agree!. No fibrinogen replacement in absence of bleeding. We know that even with 0.70 g/L we can coagulate in abs…
RT @ProfMakris: New guidance document published by a group of ISTH authors on the diagnosis and management of COVID-19 coagulopathy. All do…
RT @ProfMakris: The most important message in these two papers that are in press in JTH is that all patients with COVID-19 admitted to hosp…